Century Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 11/14/2024 | 5.41 M | $9.25 M | 0.00% | 6.39% |
VR ADVISER, LLC | 11/14/2024 | 5.39 M | $9.22 M | 0.00% | 6.36% |
BOXER CAPITAL, LLC | 11/14/2024 | 3.90 M | $6.67 M | -20.43% | 4.60% |
CASDIN CAPITAL, LLC | 11/14/2024 | 3.21 M | $5.49 M | -38.11% | 3.79% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 2.99 M | $5.11 M | 100.00% | 3.53% |
FMR LLC | 11/13/2024 | 2.52 M | $4.31 M | -14.53% | 2.98% |
VANGUARD GROUP INC | 11/13/2024 | 2.48 M | $4.23 M | 42.90% | 2.92% |
MORGAN STANLEY | 11/14/2024 | 2.27 M | $3.88 M | 892.60% | 2.68% |
DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.70 M | $2.91 M | 0.00% | 2.01% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 1.32 M | $2.26 M | 0.00% | 1.56% |
SYNCONA PORTFOLIO LTD | 11/14/2024 | 1.21 M | $2.07 M | 21.21% | 1.43% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 968,182 | $1.66 M | 3.49% | 1.14% |
TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 900,000 | $1.54 M | 0.00% | 1.06% |
STATE STREET CORP | 11/14/2024 | 836,914 | $1.43 M | 7.35% | 0.99% |
BAKER BROS. ADVISORS LP | 11/14/2024 | 797,460 | $1.36 M | 0.00% | 0.94% |
OCTAGON CAPITAL ADVISORS LP | 11/14/2024 | 666,825 | $1.14 M | -50.00% | 0.79% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 488,200 | $834,822 | 194.98% | 0.58% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 355,331 | $607,616 | -10.81% | 0.42% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 257,600 | $440,496 | 63.45% | 0.30% |
WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 166,123 | $284,071 | 100.00% | 0.20% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 140,759 | $240,698 | -62.82% | 0.17% |
ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 119,384 | $202,000 | 100.00% | 0.14% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 108,120 | $184,885 | 52.70% | 0.13% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 105,994 | $181,250 | -28.86% | 0.13% |
SQUAREPOINT OPS LLC | 11/14/2024 | 105,697 | $180,742 | 100.00% | 0.12% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 105,650 | $180,662 | 0.00% | 0.12% |
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 10/24/2024 | 78,210 | $133,739 | -0.03% | 0.09% |
JPMORGAN CHASE & CO | 12/26/2024 | 71,721 | $122,642 | 257.59% | 0.08% |
BARCLAYS PLC | 11/19/2024 | 61,945 | $106,000 | 283.61% | 0.07% |
RHUMBLINE ADVISERS | 11/12/2024 | 49,862 | $85,256 | -4.96% | 0.06% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 33,449 | $56,868 | -55.59% | 0.04% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 31,577 | $53,997 | 6.69% | 0.04% |
HARBOURVEST PARTNERS LLC | 11/14/2024 | 29,018 | $49,621 | 0.00% | 0.03% |
PARAMETRICA MANAGEMENT LTD | 11/05/2024 | 27,840 | $47,606 | 0.00% | 0.03% |
CORNERCAP INVESTMENT COUNSEL INC | 11/06/2024 | 25,978 | $44.42 M | -49.08% | 0.03% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 25,137 | $42,984 | 120.71% | 0.03% |
COREBRIDGE FINANCIAL, INC. | 11/13/2024 | 25,022 | $42,788 | 1.37% | 0.03% |
UBS GROUP AG | 11/14/2024 | 22,291 | $38,118 | 58.15% | 0.03% |
WELLS FARGO & COMPANY/MN | 11/13/2024 | 22,235 | $38,022 | 10.30% | 0.03% |
AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 20,861 | $35,672 | 100.00% | 0.02% |
ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 20,020 | $34,234 | 0.00% | 0.02% |
LYNX1 CAPITAL MANAGEMENT LP | 11/14/2024 | 19,028 | $32.54 M | 100.00% | 0.02% |
CITADEL ADVISORS LLC | 11/14/2024 | 18,486 | $31,611 | -59.07% | 0.02% |
JANE STREET GROUP, LLC | 11/15/2024 | 18,044 | $30,855 | -77.62% | 0.02% |
VOYA INVESTMENT MANAGEMENT LLC | 11/14/2024 | 17,437 | $29,817 | 0.00% | 0.02% |
SG AMERICAS SECURITIES, LLC | 10/03/2024 | 16,081 | $27,000 | 100.00% | 0.02% |
PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 14,882 | $26,000 | 0.00% | 0.02% |
NEW YORK STATE COMMON RETIREMENT FUND | 10/28/2024 | 13,743 | $24,000 | 0.00% | 0.02% |
CITADEL ADVISORS LLC | 11/14/2024 | 10,200 | $17,442 | 3,300.00% | 0.01% |
FOUNDERS FINANCIAL SECURITIES LLC | 11/12/2024 | 10,000 | $17,100 | 0.00% | 0.01% |
Century Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 69 institutional investors and hedge funds held shares of Century Therapeutics, Inc.. The most heavily invested institutionals were:
GAMMA Investing LLC: 0
Bain Capital Life Sciences Investors, LLC: 5.41 M
VR Adviser, LLC: 5.39 M
Boxer Capital, LLC: 3.9 M
Casdin Capital, LLC: 3.21 M
BlackRock Funding, Inc. /DE: 2.99 M
46.81% of Century Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 42.63 M shares in the last 24 months. This purchase volume represents approximately $39.22 M in transactions.